Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent |
Multiple Sclerosis | United States | NCT04933552 | |
A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia |
Breast Cancer | Russian Federation | NCT04943497 | |
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN |
C3 Glomerulopathy, Idiopathic Immune-complex-membranoproliferative Glomerulonephritis | Phase3 | Argentina Brazil China Czechia France Germany Greece Israel Italy Japan Netherlands Spain Switzerland Turkey United Kingdom United States View All |
NCT03955445 |
Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation |
Hidradenitis Suppurativa | France | NCT06444087 | |
Regulatory Post-Marketing Surveillance Study for Brolucizumab |
Neovascular Age-related Macular Degeneration | Korea, Republic of | NCT04985487 | |
Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria |
Uncomplicated Plasmodium Falciparum Malaria | Phase3 | Congo, The Democratic Republic of the Côte D'Ivoire India Mali Niger View All |
NCT05842954 |
A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea |
Graft-versus-Host Disease | Korea, Republic of | NCT05621733 | |
Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function |
Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Phase2 | France Germany Italy Spain View All |
NCT06004661 |
Platform Study to Evaluate the Efficacy and Safety of Anti-malarial Agents in Patients With Uncomplicated Plasmodium Falciparum Malaria |
Uncomplicated Plasmodium Falciparum Malaria | Phase2 | Côte D'Ivoire Ghana Kenya Uganda View All |
NCT05750628 |
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. |
Primary Prevention of Atherosclerotic Cardiovascular Disease | Phase3 | Argentina Australia Belgium Brazil Bulgaria Colombia Croatia Czechia Denmark Estonia France Greece Hong Kong India Israel Italy Latvia Lithuania Malaysia Mexico Netherlands Philippines Portugal Romania Singapore Slovakia South Africa Spain Sweden Taiwan Thailand Turkey United Kingdom United States Vietnam View All |
NCT05739383 |